Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study.
Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study.
复制标题
DOI：
10.1038/sj.bjc.6600945
复制
发表时间：
2003-06-02
影响因子：
8.8
通讯作者：
中科院分区：
文献类型：
--
作者：
越来越多的证据表明，使用非甾体抗炎药（NSAID）与结直肠癌风险之间存在负相关。然而，关于其他癌症部位的数据有限。使用基于人群的北日德兰处方数据库和丹麦癌症登记处的数据，我们在9年的研究期间比较了172057名处方非阿司匹林NSAID的个体的癌症发病率与预期发病率（基于县特定的癌症发病率）。NSAID使用者中共诊断出6081例新发癌症病例，而预期为5722例（标准化发病率比（SIR）1.1，95%置信区间（CI）1.0-1.1）。在获得10张或更多处方的人群中，结肠癌和直肠癌的SIR分别为0.7（95%CI 0.6-0.9）和0.6（95%CI 0.4-0.9）。同样，胃癌（SIR 0.7，95% CI 0.4-1.1）和卵巢癌（SIR 0.7，95% CI 0.4-1.0）的风险估计值也有所降低。在拥有10种或以上处方的人群中，其他癌症的标准化发病率往往接近1.0，但肺癌、肾癌和前列腺癌除外，其SIRS分别为1.3（95%CI 1.1-1.6）、1.4（95%CI 0.9-2.1）和1.6（95%CI 1.3-2.0）。我们发现非甾体抗炎药对结肠癌、直肠癌、胃癌和卵巢癌有保护作用。一些癌症部位风险增加的原因尚不清楚。
There is increasing evidence of an inverse association between use of nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of colorectal cancer. However, data regarding other cancer sites are limited. Using data from the population-based North Jutland Prescription Database and the Danish Cancer Registry, we compared cancer incidence among 172 057 individuals prescribed nonaspirin NSAIDs with expected incidence (based on county-specific cancer rates) during a 9-year study period. A total of 6081 incident cancer cases were diagnosed among NSAID users vs 5722 expected (standardised incidence ratio (SIR) 1.1, 95% confidence interval (CI)1.0–1.1). The SIRs for colon and rectal cancer among persons who obtained 10 or more prescriptions were 0.7 (95% CI 0.6–0.9) and 0.6 (95% CI 0.4–0.9), respectively. Similarly, reduced risk estimates were found for stomach (SIR 0.7, 95% CI 0.4–1.1) and ovarian cancer (SIR 0.7, 95% CI 0.4–1.0). Standardised incidence ratios for other cancers among those with 10 or more prescriptions tended to be close to 1.0, except for lung, kidney, and prostate cancers with SIRs of 1.3 (95% CI 1.1–1.6), 1.4 (95% CI 0.9–2.1), and 1.6 (95% CI 1.3–2.0), respectively. We found protective associations of NSAIDs against colon, rectal, stomach, and ovarian cancer. Reasons for the increased risk for some cancer sites are not clear.
登录
查看更多内容
影响因子：
158.5
作者：
GIOVANNUCCI, E;EGAN, KM;SPEIZER, FE
通讯作者：
SPEIZER, FE
影响因子：
4.1
作者：
Meier, CR;Schmitz, S;Jick, H
通讯作者：
Jick, H
影响因子：
105.7
作者：
PETO, R;GRAY, R;DOLL, R
通讯作者：
DOLL, R
影响因子：
--
作者：
PELEG, II;MAIBACH, HT;WILCOX, CM
通讯作者：
WILCOX, CM
影响因子：
8.8
作者：
Akhmedkhanov, A;Toniolo, P;Shore, RE
通讯作者：
Shore, RE